NCT01704521View on ClinicalTrials.gov

Viral Kinetics in HCV Clearance in Subjects With Hemophilia

PHASE1CompletedINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions

Chronic Hepatitis CHemophilia

Interventions

DRUG

PegInterferon

DRUG

Ribavirin

DRUG

Telaprevir

Trial Locations (1)

45267

UC Physicians Company, Cincinnati

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Vertex Pharmaceuticals Incorporated

INDUSTRY

collaborator

Genentech, Inc.

INDUSTRY

lead

Kenneth Sherman

OTHER